MGC Pharmaceuticals Ltd (ASX: MXC) has reported that the number of patients being prescribed its cannabinoid medicines has now passed the key milestone of 600 in Australia & the United Kingdom.
- Prescriptions were 400 at the end of September.
- Average 19 prescriptions issued per day to date in October.
- MXC is working closely with distributors to onboard further clinics.
By 12:39 PM AEST, MXC was quoting at $0.036, up by 5.9% from the last close.